iRadimed Posts Record $24.2M Q3 Revenue, Narrows Full-Year Guidance and Declares $0.20 Dividend
IRMD is trading near its 52-week low of $75.75 (10% above the low).
Summary
iRadimed reported record Q3 revenue of $24.2 million, up 14% year over year, with GAAP diluted EPS of $0.51. It narrowed full-year revenue guidance to $91.6 million-$93.1 million and declared a $0.20 quarterly dividend.
Key Events · Earnings and Guidance · IRMD
-
Record Q3 Revenue of $24.2M
Revenue rose $3.0 million, or 14%, from $21.2 million a year ago and $3.7 million, or 18%, from Q2 2026. GAAP diluted EPS was $0.51 versus $0.43 a year ago; non-GAAP diluted EPS was $0.55.
-
Full-Year Guidance Range Narrowed
FY2026 revenue guidance cut to $91.6 million-$93.1 million from $91.0 million-$96.0 million, and GAAP diluted EPS to $1.90-$1.94 from $1.90-$2.05. Q4 guidance is $25.0 million-$26.5 million revenue and $0.53-$0.57 GAAP diluted EPS.
-
$0.20 Quarterly Dividend Declared
Payable November 27, 2026 to stockholders of record as of November 13, 2026, backed by $63.3 million in cash and cash equivalents at September 30, 2026.
-
Gross Margin Slips to 76%
Down from 78% a year ago as the 3870 pump platform ramps, though management said margin improved sequentially as production efficiencies materialized. Record quarterly bookings included a 45% year-over-year increase in domestic pump channels.
Analysis · IRMD · Industrial Applications And Services
Revenue of $24.2 million beat the prior quarter by 18% and the year-ago period by 14%, with management citing record quarterly bookings and a 45% year-over-year increase in domestic pump channels booked as the new 3870 pump ramps. The catch is guidance: the full-year revenue range was narrowed to $91.6 million-$93.1 million from $91.0 million-$96.0 million, and GAAP EPS to $1.90-$1.94 from $1.90-$2.05 — the top end came down even as the bottom held, so the quarter is strong but the year is being de-risked rather than raised. Gross margin slipped to 76% from 78% a year ago as the new platform ramps, though it improved sequentially. The $0.20 quarterly dividend payable November 27, 2026 keeps a cash-return commitment in place against $63.3 million of cash.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IRMD was trading at $83.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $75.75 to $107.90. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.